Browsing by Author Hamet, Pavel

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 28  next >
Issue DateTitleAuthor(s)Citation
2009Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in DiabetesCass, Alan; Chalmers, John; de Galan, Bastiaan; Jardine, Meg; MacMahon, Stephen; Neal, Bruce; Ninomiya, Toshiharu; Patel, Anushka; Perkovic, Vlado; Pillai, Avineshwaran; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; Hamet, Pavel; Mancia, Giuseppe; Marre, Michel; Mogensen, Carl-Erik; Poulter, Neil; Williams, Bryan; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; School of Public Health: NH&MRC Clinical Trials Centre; The George Institute for International Health; The George Institute for International HealthAlbuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes, Journal of the American Society of Nephrology, vol.20, 8,pp 1813-1821
2012Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholdsChalmers, John; Colagiuri, Stephen; Fulcher, Greg; Neal, Bruce; Patel, Anushka; Woodward, Mark; Cooper, M; de Galan, B; Hamet, Pavel; Harrap, Stephen B.; Heller, Simon; Li, Q; MacMahon, Stephen; Marre, Michel; Ninomiya, T; Poulter, Neil; Travert, F; Zoungas, Sophia; The George Institute for Global Health; Central Clinical School: Medicine; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthAssociation of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds, Diabetologia: clinical and experimental diabetes and metabolism, vol.55, 3, 2012,pp 636-643
2017Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: The ADVANCE trialChalmers, John; Jun, Min; Ohkuma, Toshiaki; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; Grobbee, Diederick E; Hamet, Pavel; Mancia, Giuseppe; Rahimi, Kazem; Sattar, Naveed; Shaw, Jonathan E; Welsh, P.; Williams, Bryan; The George Institute for Global Health; School of Public Health: Public Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthCardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: The ADVANCE trial, Diabetes Care, vol.40, 9, 2017,pp 1203-1209
2016Changes in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE StudyArima, Hisatomi; Chalmers, John; Hayes, Alison; Woodward, Mark; Clarke, Philip M; Hamet, Pavel; Poulter, Neil; The George Institute for Global Health; The George Institute for Global Health; School of Public Health: Public Health; The George Institute for Global HealthChanges in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE Study, Value in Health, vol.19, 1, 2016,pp 36-41
2013Circulating bone morphogenetic protein-7 and transforming growth factor-(beta)1 are better predictors of renal end points in patients with type 2 diabetes mellitusAzari, Ehsanulla; Chalmers, John; Hillis, Graham; Jun, Min; Li, Qiang; Neal, Bruce; Perkovic, Vlado; Pollock, Carol; Wong, Muh; Woodward, Mark; Cooper, Mark; Hamet, Pavel; Mancia, Giuseppe; Poulter, Neil; Williams, Bryan; Northern Clinical School: Kolling Institute; The George Institute for Global Health; The George Institute for Global Health; School of Public Health: Public Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; Northern Clinical School: Medicine; Northern Clinical School: Medicine; The George Institute for Global HealthCirculating bone morphogenetic protein-7 and transforming growth factor-(beta)1 are better predictors of renal end points in patients with type 2 diabetes mellitus, Kidney International, vol.83, 2, 2013,pp 278-284
2014Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE StudyChalmers, John; Hillis, Graham; Li, Qiang; Patel, Anushka; Woodward, Mark; Hamet, Pavel; Harrap, Stephen; Lowe, Gordon; Marre, Michel; Poulter, Neil; Rumley, Ann; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthCirculating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study, Diabetes, vol.63, 3, 2014,pp 1115-1123
2009Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trialAnderson, Craig; Chalmers, John; de Galan, Bastiaan; Hackett, Maree; MacMahon, Stephen; Neal, Bruce; Patel, Anushka; Pillai, Avineshwaran; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; Dufouil, C; Grobbee, D; Hamet, Pavel; Heller, Simon; Lisheng, Liu; Mancia, Giuseppe; Pan, C; Poulter, N.; Travert, F; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; School of Public Health: NH&MRC Clinical Trials Centre; The George Institute for International Health; The George Institute for International HealthCognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial, Diabetologia: clinical and experimental diabetes and metabolism, vol.52, 11,pp 2328-2336
2009The combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCEChalmers, John; de Galan, Bastiaan; MacMahon, Stephen; Neal, Bruce; Ninomiya, Toshiharu; Patel, Anushka; Woodward, Mark; Zoungas, Sophia; Grobbee, Diederick; Hamet, Pavel; Heller, Simon; Marre, Michel; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthThe combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCE, Diabetes Care, vol.32, 11,pp 2068-2074
2009Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetesBillot, Laurent; Bompoint, Severine; Chalmers, John; de Galan, Bastiaan; Joshi, Rohina; MacMahon, Stephen; Neal, Bruce; Patel, Anushka; Woodward, Mark; Cooper, Mark; Glasziou, Paul; Grobbee, Diederick E.; Hamet, Pavel; Harrap, Stephen B.; Heller, Simon; Liu, Lisheng; Mancia, Giuseppe; Marre, Michel; Mogensen, Carl-Erik; Pan, C; Poulter, Neil; Rodgers, Anthony; Travert, F; Williams, Bryan; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthEffects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes, New England Journal of Medicine, vol.358,(24),2009,pp 2560-2572
2013Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The ADVANCE trialAnderson, Craig; Arima, Hisatomi; Chalmers, John; Hata, Jun; MacMahon, Stephen; Neal, Bruce; Patel, Anushka; Woodward, Mark; Zoungas, Sophia; Glasziou, Paul; Hamet, Pavel; Mancia, Giuseppe; Poulter, Neil; Rothwell, Peter; Williams, Bryan; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthEffects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The ADVANCE trial, Circulation, vol.128, 12, 2013,pp 1325-1334
2010Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trialCass, Alan; Chalmers, John; MacMahon, Stephen William; Neal, Bruce; Ninomiya, Toshiharu; Patel, Anushka; Perkovic, Vlado; Rodgers, Anthony; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; Grobbee, Diederick; Hamet, Pavel; Harrap, Stephen B.; Liu, Lisheng; Mancia, Giuseppe; Mogensen, Carl-Erik; Poulter, Neil; Williams, Bryan; School of Public Health: Medicine; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthEfficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial, Journal of Hypertension, vol.28, 6, 2010,pp 1141-1149
2015Endothelial Gata5 transcription factor regulates blood pressureChalmers, John; et al, Various; Gutsol, Alex; Hamet, Pavel; He, Ying; Hebert, Richard L; Makrigiannis, Andrew P; McPherson, Ruth; Messaoudi, Smail; Tremblay, Johanne; Vilmundarson, Ragnar; Wight, Andrew; The George Institute for Global HealthEndothelial Gata5 transcription factor regulates blood pressure, Nature Communications, vol.6, N/A, 2015,pp 1-13
2010Erectile Dysfunction and Later Cardiovascular Disease in Men With Type 2 Diabetes: Prospective Cohort Study Based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation) TrialChalmers, John; Huxley, Rachel; Neal, Bruce; Patel, Anushka; Woodward, Mark; Batty, G. David; Czernichow, Sebastien; de Galan, Bastiaan E.; Hamet, Pavel; Harrap, Stephen B.; Li, Q; Poulter, Neil; Zoungas, Sophia; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthErectile Dysfunction and Later Cardiovascular Disease in Men With Type 2 Diabetes: Prospective Cohort Study Based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation) Trial, Journal of the American College of Cardiology, vol.56, 23,pp 1908-1913
2017Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk geneChalmers, John; Woodward, Mark; Bradley, Edward; Hamet, Pavel; Harrap, S; Luo, Hongyu; Marois-Blanchet, Francois-Christophe; Raelson, John; Tremblay, Johanne; Wang, Yujia; Wu, Jiangping; Wu, Zenghui; The George Institute for Global Health; The George Institute for Global HealthEvidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene, Scientific Reports, vol.7, N/A, 2017,pp 1-10
2014Follow-up of blood-pressure lowering and glucose control in type 2 diabetesArima, Hisatomi; Billot, Laurent; Chalmers, John; Colagiuri, Stephen; Hirakawa, Yoichiro; Joshi, Rohina; Li, Qiang; MacMahon, Stephen William; Monaghan, Helen; Neal, Bruce; Patel, Anushka; Perkovic, Vlado; Rodgers, Anthony; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; et al, Various; Glasziou, Paul P; Grobbee, Diederick E.; Hamet, Pavel; Harrap, Stephen; Heller, Simon; Lisheng, Liu; Mancia, Giuseppe; Marre, Michel; Matthews, David. R.; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; Boden Institute; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthFollow-up of blood-pressure lowering and glucose control in type 2 diabetes, The New England Journal of Medicine, vol.371, 15, 2014,pp 1392-1406
2010The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: PreteraxChalmers, John; Colagiuri, Stephen; Kengne, Andre; Neal, Bruce; Patel, Anushka; Woodward, Mark; Grobbee, Diederick E.; Hamet, Pavel; Heller, Simon; Marre, Michel; Pan, C; Zoungas, Sophia; The George Institute for International Health; Central Clinical School: Medicine; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthThe Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax, Diabetologia: clinical and experimental diabetes and metabolism, vol.53, 5,pp 821-831
2014Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetesChalmers, John; Li, Qiang; Patel, Anushka; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; Hamet, Pavel; Harrap, Stephen; Heller, Simon; Marre, Michel; Poulter, Neil; Williams, Bryan; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthImpact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes, Diabetologia, vol.57, 12, 2014,pp 2465-2474
2014Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE TrialArima, Hisatomi; Chalmers, John; Hirakawa, Yoichiro; Ninomiya, Toshiharu; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; Hamet, Pavel; Harrap, Stephen; Mancia, Giuseppe; Poulter, Neil; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthImpact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial, Diabetes Care, vol.37, 8, 2014,pp 2359-2365
2014Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trialChalmers, John; Colagiuri, Stephen; Kengne, Andre; Neal, Bruce; Patel, Anushka; Van Dieren, Susan; Woodward, Mark; Zoungas, Sophia; Beulens, Joline W. J.; Davis, T. M. E.; Fulcher, Greg R.; Hamet, Pavel; Heller, Simon; Mancia, Giuseppe; Marre, Michel; Peelen, Linda; van der Schouw, Yvonne T; Williams, Bryan; The George Institute for Global Health; Boden Institute; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthIntensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial, Diabetes, Obesity and Metabolism, vol.16, 5, 2014,pp 426-432
2008Intensive blood glucose control and vascular outcomes in patients with type 2 diabetesBillot, Laurent; Chalmers, John; Joshi, Rohina; MacMahon, Stephen; Neal, Bruce; Patel, Anushka; Woodward, Mark; Cooper, Mark; et, al; Glasziou, Paul; Grobbee, Diederick; Hamet, Pavel; Harrap, Stephen B.; Heller, Simon; Liu, Lisheng; Mancia, Giuseppe; Marre, Michel; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes, New England Journal of Medicine, vol.358,(24),2008,pp 2560-2572